chrX-152846330-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6BP7
The NM_015922.3(NSDHL):c.6A>G(p.Glu2Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: not found (cov: 24)
Consequence
NSDHL
NM_015922.3 synonymous
NM_015922.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.555
Genes affected
NSDHL (HGNC:13398): (NAD(P) dependent steroid dehydrogenase-like) The protein encoded by this gene is localized in the endoplasmic reticulum and is involved in cholesterol biosynthesis. Mutations in this gene are associated with CHILD syndrome, which is a X-linked dominant disorder of lipid metabolism with disturbed cholesterol biosynthesis, and typically lethal in males. Alternatively spliced transcript variants with differing 5' UTR have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant X-152846330-A-G is Benign according to our data. Variant chrX-152846330-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 3044975.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-0.555 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NSDHL | NM_015922.3 | c.6A>G | p.Glu2Glu | synonymous_variant | 2/8 | ENST00000370274.8 | NP_057006.1 | |
NSDHL | NM_001129765.2 | c.6A>G | p.Glu2Glu | synonymous_variant | 3/9 | NP_001123237.1 | ||
NSDHL | XM_017029564.2 | c.54A>G | p.Glu18Glu | synonymous_variant | 2/8 | XP_016885053.1 | ||
NSDHL | XM_011531178.3 | c.6A>G | p.Glu2Glu | synonymous_variant | 4/10 | XP_011529480.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NSDHL | ENST00000370274.8 | c.6A>G | p.Glu2Glu | synonymous_variant | 2/8 | 1 | NM_015922.3 | ENSP00000359297.3 | ||
NSDHL | ENST00000440023.5 | c.6A>G | p.Glu2Glu | synonymous_variant | 3/9 | 5 | ENSP00000391854.1 | |||
NSDHL | ENST00000432467.1 | c.6A>G | p.Glu2Glu | synonymous_variant | 3/8 | 3 | ENSP00000396266.1 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD3 genomes
Cov.:
24
GnomAD4 exome Cov.: 29
GnomAD4 exome
Cov.:
29
GnomAD4 genome Cov.: 24
GnomAD4 genome
Cov.:
24
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
NSDHL-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 04, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.